Raftlin Activators comprise a suite of chemical compounds that can indirectly influence the cellular and biochemical processes associated with Raftlin, mainly through the modulation of lipid raft dynamics where Raftlin is localized. Cholesterol and sphingomyelin are fundamental constituents of lipid rafts and their respective enrichment in the plasma membrane can enhance the structural stability and functionality of these specialized membrane microdomains, thereby indirectly amplifying Raftlin's activity. Similarly, glycosphingolipid contributes to the architectural integrity of lipid rafts, affecting Raftlin's functional state. Fingolimod and cholera toxin subunit B both interact with components of lipid rafts, which can lead to altered signaling events influencing Raftlin's role. Phorbol 12-myristate 13-acetate (PMA), through the activation of protein kinase C, and forskolin, by increasing intracellular cyclic AMP (cAMP), both exert their effects on signaling pathways that are intertwined with lipid raft-mediated processes where Raftlin operates, thereby indirectly enhancing its activity. Additionally, Ionomycin's role as a calcium ionophore introduces alterations in calcium-dependent signaling pathways that intersect with Raftlin's functional milieu within lipid rafts.
Raftlin is also affected by compounds that alter lipid raft composition and signaling. Methyl-β-cyclodextrin, which extracts cholesterol, and simvastatin, an HMG-CoA reductase inhibitor that reduces cholesterol synthesis, can modify the lipid raftenvironment, potentially influencing Raftlin's activity due to changes in raft dynamics and composition. Bisindolylmaleimide I, as a PKC inhibitor, can modulate the activity of this kinase, thereby impacting the signaling pathways that affect Raftlin operation within lipid rafts. The interplay of these chemical activators underscores the intricate regulation of Raftlin through the manipulation of lipid raft-associated signaling cascades. Collectively, these compounds, by targeting various aspects of lipid raft integrity and signaling, facilitate the enhancement of Raftlin's role in immune cell signaling and other raft-dependent processes without directly increasing its expression levels or requiring direct activation of the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
Cholesterol is a key component of lipid rafts. By integrating into plasma membrane, it can enhance the stabilization of lipid rafts, thereby potentially increasing the functional activity of Raftlin, which is known to associate with lipid rafts. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $180.00 $560.00 | 3 | |
Sphingomyelin is a phospholipid that contributes to the structure of lipid rafts. Its presence in the membrane can promote the integrity of these microdomains, indirectly enhancing the activity of Raftlin as it is localized within these areas. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which is involved in signal transduction pathways that intersect with lipid raft-mediated processes. Activation of PKC can influence Raftlin's function within these rafts. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP acts as a secondary messenger in various signaling pathways and can modulate the function of Raftlin by influencing the signaling environments of lipid rafts where Raftlin is localized. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, thus potentially enhancing Raftlin activity by modifying the signaling dynamics within lipid rafts. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that can increase intracellular calcium levels, potentially affecting Raftlin activity by changing the signaling context of lipid rafts through calcium-dependent pathways. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin can extract cholesterol from membranes, indirectly affecting Raftlin by altering the lipid composition and the functional status of lipid rafts. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine-1-phosphate receptor modulator which can impact signaling pathways within lipid rafts, potentially altering Raftlin activity as part of the signaling cascade. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that can modify PKC activity, thereby influencing Raftlin activity indirectly through changes in lipid raft-associated signaling. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin inhibits HMG-CoA reductase, leading to reduced cholesterol synthesis. This can influence Raftlin by changing the cholesterol content and dynamics within lipid rafts. | ||||||